IP Verse

Seventy Bio competitive analysis

Latest publications and patents of Seventy Bio New

Explore the latest publications and patents granted to Seventy Bio, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Seventy Bio

EP3689899
Nov 24, 2021Mnd Promoter Chimeric Antigen ReceptorsGranted And Under Opposition
EP3134095
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell TherapiesGranted And Under Opposition
EP3134432
Dec 25, 2019Mnd Promoter Chimeric Antigen ReceptorsGranted And Under Opposition

Latest patents of Seventy Bio opposed by its competitors

Explore Seventy Bio's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3689899
Nov 24, 2021Mnd Promoter Chimeric Antigen Receptors1
EP3134095
Apr 22, 2020Improved Methods For Manufacturing Adoptive Cell Therapies3
EP3134432
Dec 25, 2019Mnd Promoter Chimeric Antigen Receptors1

Latest PTAB cases involving Seventy Bio

Discover the latest PTAB cases involving Seventy Bio, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Seventy Bio with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SEVENTY BIO - 5 - - Non-Active
BOULT WADE TENNANT52 - - - Highly Aggressive
DEHNS11 - - - Highly Aggressive
GLAXOSMITHKLINE29112812Defensive